COVID-19患者入住ICU后2个月和12个月的健康相关生活质量
该研究纳入2020年4月至6月间从ICU出院并转入住院康复机构的94例COVID-19患者,在ICU入院后2个月和12个月评估健康相关生活质量(EQ-5D-3L)和呼吸困难(mMRC)。2个月与12个月的中位EQ-5D-3L时间权衡评分分别为0.80和0.91(P=0.12),视觉模拟评分均为70(P=0.07);mMRC在ICU出院时为3,2个月时降至1(P<0.001),12个月时为1。12个月时68例(76%)报告至少一种ICU入院前不存在的症状,44例既往工作者中27例(61%)已重返工作;多因素线性回归显示与EQ-5D-3L相关的因素包括ICU入院时体重指数、气管切开、男性性别和主动吸烟。
要点
- 12个月时68例(76%)报告至少一种ICU入院前不存在的症状,44例既往工作者中27例(61%)已重返工作。
- mMRC呼吸困难评分从ICU出院时的3降至2个月时的1(P<0.001),12个月时仍为1。
- 2个月与12个月的中位EQ-5D-3L时间权衡评分分别为0.80和0.91(P=0.12),视觉模拟评分均为70(P=0.07)。
- 多因素线性回归显示与EQ-5D-3L相关的因素包括ICU入院时体重指数、气管切开、男性性别和主动吸烟。
适用人群与场景
- 2020年4月至6月从ICU出院并随后转入住院康复机构的COVID-19患者。
研究设计与关键结果
- 研究类型:对ICU出院后转入住院康复机构的COVID-19患者进行2个月和12个月随访评估。
- 样本量:共纳入94例患者。
- 主要终点:中位EQ-5D-3L时间权衡评分2个月为0.80(四分位距0.36-0.91),12个月为0.91(0.52-1.00),P=0.12。
- 次要终点:EQ-5D-3L视觉模拟评分2个月为70(60-85),12个月为70(60-85),P=0.07。
- 次要终点:mMRC呼吸困难评分ICU出院时为3(2-4),2个月时为1(0-2),P<0.001,12个月时为1(1-2)。
- 12个月时,68例(76%)报告至少一种ICU入院前不存在的症状;44例既往工作者中27例(61%)已重返工作。
- 多因素线性回归显示,与EQ-5D-3L相关的因素包括ICU入院时体重指数、气管切开、男性性别和主动吸烟。
证据类型、等级与局限
- 证据类型:对ICU出院后转入住院康复机构的COVID-19患者进行2个月和12个月随访评估的研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与12个月生活质量较差风险相关的因素可能有助于识别高危患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To describe health-related quality of life (HRQoL) and dyspnea of COVID-19, 2 and 12 months after an intensive care unit (ICU) stay.
METHODS: Patients discharged from the ICU between April and June 2020 and subsequently transferred to an inpatient rehabilitation facility were assessed 2 months and 12 months after ICU admission. HRQoL was assessed by the EuroQoL EQ-5D-3L (visual analog scale and time trade-off normalized to the French population algorithm) and dyspnea was assessed by the modified Medical Research Council (mMRC) dyspnea scale.
RESULTS: We enrolled 94 patients. Median EQ-5D-3L time trade-off was 0.80 (interquartile range, 0.36-0.91) at 2 months and 0.91 (0.52-1.00) at 12 months (P = 0.12). EQ-5D-3L visual analog scale was 70 (60-85) at 2 months and 70 (60-85) at 12 months (P = 0.07). The mMRC dyspnea scale was 3 (2-4) at ICU discharge, 1 (0-2), P < 0.001 at 2 months and 1 (1-2) at 12 months. At 12 months, 68 (76%) patients reported at least one symptom that was not present prior to ICU admission and 27 (61%) of the 44 patients who were previously working had returned to work. On multiple linear regression, factors associated with EQ-5D-3L were body mass index on ICU admission, tracheostomy, male gender and active smoking.
CONCLUSIONS: Twelve months after ICU admission for COVID-19 and subsequent rehabilitation, a substantial proportion of patients reported alterations of HRQoL, dyspnea and symptoms that were not present prior to admission and a substantial proportion of these patients had not returned to work. Factors associated with a risk of poorer 12-month quality of life, may help to identify at-risk patients.
参考来源
- Demoule A, Morawiec E, Decavele M, et al. Health-related quality of life of COVID-19 two and 12 months after intensive care unit admission. Ann Intensive Care. 2022. PMID: 35184214. doi:10.1186/s13613-022-00991-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。